<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35151371</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4180</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>Immunity</Title><ISOAbbreviation>Immunity</ISOAbbreviation></Journal><ArticleTitle>Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease.</ArticleTitle><Pagination><StartPage>542</StartPage><EndPage>556.e5</EndPage><MedlinePgn>542-556.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.immuni.2022.01.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1074-7613(22)00046-2</ELocationID><Abstract><AbstractText>Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for many months. We delineated the immune-proteomic landscape in the airways and peripheral blood of healthy controls and post-COVID-19 patients 3 to 6&#xa0;months after hospital discharge. Post-COVID-19 patients showed abnormal airway (but not plasma) proteomes, with an elevated concentration of proteins associated with apoptosis, tissue repair, and epithelial injury versus healthy individuals. Increased numbers of cytotoxic lymphocytes were observed in individuals with greater airway dysfunction, while increased B cell numbers and altered monocyte subsets were associated with more widespread lung abnormalities. A one-year follow-up of some post-COVID-19 patients indicated that these abnormalities resolved over time. In summary, COVID-19 causes a prolonged change to the airway immune landscape in those with persistent lung disease, with evidence of cell death and tissue repair linked to the ongoing activation of cytotoxic T&#xa0;cells.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vijayakumar</LastName><ForeName>Bavithra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Chelsea and Westminster Hospital, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boustani</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Asthma UK Centre for Allergic Mechanisms of Asthma, London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogger</LastName><ForeName>Patricia P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadaki</LastName><ForeName>Artemis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonkin</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orton</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghai</LastName><ForeName>Poonam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suveizdyte</LastName><ForeName>Kornelija</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewitt</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Sujal R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK; Margaret Turner-Warwick Centre for Fibrosing Lung Diseases, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devaraj</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snelgrove</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Asthma UK Centre for Allergic Mechanisms of Asthma, London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molyneaux</LastName><ForeName>Philip L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garner</LastName><ForeName>Justin L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Chelsea and Westminster Hospital, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>James E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Pallav L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Chelsea and Westminster Hospital, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Clare M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Asthma UK Centre for Allergic Mechanisms of Asthma, London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harker</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Asthma UK Centre for Allergic Mechanisms of Asthma, London, London, UK. Electronic address: j.harker@imperial.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S004068/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V027638/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunity</MedlineTA><NlmUniqueID>9432918</NlmUniqueID><ISSNLinking>1074-7613</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007162">Immunoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007162" MajorTopicYN="N">Immunoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012137" MajorTopicYN="N">Respiratory System</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013602" MajorTopicYN="N">T-Lymphocytes, Cytotoxic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">airways</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">respiratory tract</Keyword><Keyword MajorTopicYN="N">respiratory viral infection</Keyword><Keyword MajorTopicYN="N">tissue-resident memory</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>13</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35151371</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pii">S1074-7613(22)00046-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ali M.F., Egan A.M., Shaughnessy G.F., Anderson D.K., Kottom T.J., Dasari H., Van Keulen V.P., Aubry M.C., Yi E.S., Limper A.H., et al. Antifibrotics modify B-cell-induced fibroblast migration and activation in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2021;64:722&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456878</ArticleId><ArticleId IdType="pubmed">33689587</ArticleId></ArticleIdList></Reference><Reference><Citation>Allden S.J., Ogger P.P., Ghai P., McErlean P., Hewitt R., Toshner R., Walker S.A., Saunders P., Kingston S., Molyneaux P.L., et al. The transferrin receptor CD71 delineates functionally distinct airway macrophage subsets during idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2019;200:209&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6635794</ArticleId><ArticleId IdType="pubmed">31051082</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam P.S., Wimmers F., Mok C.K.P., Perera R.A.P.M., Scott M., Hagan T., Sigal N., Feng Y., Bristow L., Tak-Yin Tsang O., et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369:1210&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai Y., Chiba H., Nishikiori H., Kamekura R., Yabe H., Kondo S., Miyajima S., Shigehara K., Ichimiya S., Takahashi H. Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis. Respir. Res. 2019;20:244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836348</ArticleId><ArticleId IdType="pubmed">31694639</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd D.F., Allen E.K., Randolph A.G., Guo X.J., Weng Y., Sanders C.J., Bajracharya R., Lee N.K., Guy C.S., Vogel P., et al. Exuberant fibroblast activity compromises lung function via ADAMTS4. Nature. 2020;587:466&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883627</ArticleId><ArticleId IdType="pubmed">33116313</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne A.J., Powell J.E., O'Sullivan B.J., Ogger P.P., Hoffland A., Cook J., Bonner K.L., Hewitt R.J., Wolf S., Ghai P., et al. Dynamics of human monocytes and airway macrophages during healthy aging and after transplant. J.&#xa0;Exp. Med. 2020;217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7062517</ArticleId><ArticleId IdType="pubmed">31917836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., John Wherry E.J. T cell responses in patients with COVID-19. Nat. Rev. Immunol. 2020;20:529&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7389156</ArticleId><ArticleId IdType="pubmed">32728222</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon I.S., Li C., Son Y.M., Goplen N.P., Wu Y., Cassmann T., Wang Z., Wei X., Tang J., Li Y., et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci. Immunol. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., Grifoni A., Ramirez S.I., Haupt S., Frazier A., et al. Immunological memory to SARS-CoV-2 assessed for up to 8&#xa0;months after infection. Science. 2021;371</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai O., Winkler J., Minasyan M., Herzog E.L. The role of immune and inflammatory cells in idiopathic pulmonary fibrosis. Front. Med. (Lausanne) 2018;5:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869935</ArticleId><ArticleId IdType="pubmed">29616220</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F., Carson G., et al. Features of 20 133&#xa0;UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake T.M., Riad A.M., Fairfield C.J., Egan C., Knight S.R., Pius R., Hardwick H.E., Norman L., Shaw C.A., McLean K.A., et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021;398:223&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285118</ArticleId><ArticleId IdType="pubmed">34274064</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan S., Thomas P.G. Balancing immune protection and immune pathology by CD8(+) T-cell responses to influenza infection. Front. Immunol. 2016;7:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742794</ArticleId><ArticleId IdType="pubmed">26904022</ArticleId></ArticleIdList></Reference><Reference><Citation>Evren E., Ringqvist E., Tripathi K.P., Sleiers N., Rives I.C., Alisjahbana A., Gao Y., Sarhan D., Halle T., Sorini C., et al. Distinct developmental pathways from blood monocytes generate human lung macrophage diversity. Immunity. 2021;54:259&#x2013;275.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33382972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri L., Moss S., Khan F., Chi W., Xia J., Robinson K., Smyth A., Jenkins G., Stewart I. Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Preprint at medRxiv. 2021 medRxiv:2021.2003.2015.21253593.</Citation><ArticleIdList><ArticleId IdType="pubmed">35338102</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin M.R., Mehta A., Schneider A.M., Kays K.R., Guess J.R., Gentili M., Fenyves B.G., Charland N.C., Gonye A.L.K., Gushterova I., et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep. Med. 2021;2:100287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisby J., Clarke C.L., Medjeral-Thomas N., Malik T.H., Papadaki A., Mortimer P.M., Buang N.B., Lewis S., Pereira M., Toulza F., et al. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death. Elife. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064756</ArticleId><ArticleId IdType="pubmed">33704068</ArticleId></ArticleIdList></Reference><Reference><Citation>Grau-Exp&#xf3;sito J., S&#xe1;nchez-Gaona N., Massana N., Suppi M., Astorga-Gamaza A., Perea D., Rosado J., Falc&#xf3; A., Kirkegaard C., Torrella A., et al. Peripheral and lung resident memory T&#xa0;cell responses against SARS-CoV-2. Nat. Commun. 2021;12:3010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140108</ArticleId><ArticleId IdType="pubmed">34021148</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.O., Brutsche M., Clarenbach C., Garzoni C., Geiser T.K., Lenoir A., Mancinetti M., et al. Pulmonary function and radiological features 4&#xa0;months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur. Respir. J. 2021;57:2003690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., Li Y., Cao Y., Gu J., Wu H., et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299:E177&#x2013;E186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Harker J.A., Lloyd C.M. Overlapping and distinct features of viral and allergen immunity in the human lung. Immunity. 2021;54:617&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">33852829</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi R., Wu B.G., Barnett J., Ghai P., Kingston S., Hewitt R.J., Feary J., Li Y., Chua F., Wu Z., et al. The respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2021;203:339&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874329</ArticleId><ArticleId IdType="pubmed">32692582</ArticleId></ArticleIdList></Reference><Reference><Citation>Jozwik A., Habibi M.S., Paras A., Zhu J., Guvenel A., Dhariwal J., Almond M., Wong E.H.C., Sykes A., Maybeno M., et al. RSV-specific airway resident memory CD8+ T&#xa0;cells and differential disease severity after experimental human infection. Nat. Commun. 2015;6:10224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703893</ArticleId><ArticleId IdType="pubmed">26687547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.S., Hufford M.M., Sun J., Fu Y.X., Braciale T.J. Antigen persistence and the control of local T&#xa0;cell memory by migrant respiratory dendritic cells after acute virus infection. J.&#xa0;Exp. Med. 2010;207:1161&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2882836</ArticleId><ArticleId IdType="pubmed">20513748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kory P., Kanne J.P. SARS-CoV-2 organising pneumonia: &#x201c;Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?&#x201d;. BMJ Open Respir. Res. 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7509945</ArticleId><ArticleId IdType="pubmed">32963028</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A.G., Lorenc A., Del Molino Del Barrio I., Das A., Fish M., Monin L., Mu&#xf1;oz-Ruiz M., McKenzie D.R., Hayday T.S., Francos-Quijorna I., et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 2020;26:1623&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P., Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhang Z., Yang L., Lian X., Xie Y., Li S., Xin S., Cao P., Lu J. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience. 2020;23:101160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219414</ArticleId><ArticleId IdType="pubmed">32405622</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M., Liu Y., Yuan J., Wen Y., Xu G., Zhao J., Cheng L., Li J., Wang X., Wang F., et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020;26:842&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., et al. Long-COVID&#x201d;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19. Thorax. 2021;76:396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann E.R., Menon M., Knight S.B., Konkel J.E., Jagger C., Shaw T.N., Krishnan S., Rattray M., Ustianowski A., Bakerly N.D., et al. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci. Immunol. 2020;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857390</ArticleId><ArticleId IdType="pubmed">32943497</ArticleId></ArticleIdList></Reference><Reference><Citation>Misharin A.V., Morales-Nebreda L., Reyfman P.A., Cuda C.M., Walter J.M., McQuattie-Pimentel A.C., Chen C.I., Anekalla K.R., Joshi N., Williams K.J.N., et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J.&#xa0;Exp. Med. 2017;214:2387&#x2013;2404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5551573</ArticleId><ArticleId IdType="pubmed">28694385</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto Y., Hirahara K., Kiuchi M., Wada T., Ichikawa T., Kanno T., Okano M., Kokubo K., Onodera A., Sakurai D., et al. Amphiregulin-producing pathogenic memory T Helper 2 cells instruct eosinophils to secrete osteopontin and facilitate airway fibrosis. Immunity. 2018;49:134&#x2013;150. e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29958800</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall K.J., Mukherjee B., Castanheira A.M., Lam J.L., Benedetti G., Mak S.M., Preston R., Thillai M., Dewar A., Molyneaux P.L., et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann. Am. Thorac. Soc. 2021;18:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverino F., Seys L.J., Bracke K.R., Owen C.A. B cells in chronic obstructive pulmonary disease: moving to center stage. Am. J. Physiol. Lung Cell. Mol. Physiol. 2016;311:L687&#x2013;L695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5142126</ArticleId><ArticleId IdType="pubmed">27542809</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon M.M.L., Rybkina K., Kato Y., Kubota M., Matsumoto R., Bloom N.I., Zhang Z., Hastie K.M., Grifoni A., Weiskopf D., et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci. Immunol. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626868</ArticleId><ArticleId IdType="pubmed">34618554</ArticleId></ArticleIdList></Reference><Reference><Citation>Pribul P.K., Harker J., Wang B., Wang H., Tregoning J.S., Schwarze J., Openshaw P.J. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J.&#xa0;Virol. 2008;82:4441&#x2013;4448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2293049</ArticleId><ArticleId IdType="pubmed">18287232</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj V.S., Mou H., Smits S.L., Dekkers D.H., M&#xfc;ller M.A., Dijkman R., Muth D., Demmers J.A., Zaki A., Fouchier R.A., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095326</ArticleId><ArticleId IdType="pubmed">23486063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez L., Pekkarinen P.T., Lakshmikanth T., Tan Z., Consiglio C.R., Pou C., Chen Y., Mugabo C.H., Nguyen N.A., Nowlan K., et al. Systems-level immunomonitoring from acute to recovery phase of severe COVID-19. Cell Rep. Med. 2020;1:100078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405891</ArticleId><ArticleId IdType="pubmed">32838342</ArticleId></ArticleIdList></Reference><Reference><Citation>Saris A., Reijnders T.D.Y., Nossent E.J., Schuurman A.R., Verhoeff J., Asten S.V., Bontkes H., Blok S., Duitman J., Bogaard H.J., et al. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19. Thorax. 2021;76:1010&#x2013;1019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050882</ArticleId><ArticleId IdType="pubmed">33846275</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M.E., Varga S.M. The CD8 T&#xa0;cell response to respiratory virus infections. Front. Immunol. 2018;9:678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5900024</ArticleId><ArticleId IdType="pubmed">29686673</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott N.A., Knight S.B., Pearmain L., Brand O., Morgan D.J., Jagger C., Khan S., Hackney P., Smith L., Menon M., et al. Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 convalescence. Preprint at medRxiv. 2020 medRxiv:2020.2010.2010.20207449.</Citation></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Preprint at medRxiv. 2021 medRxiv:2021.2003.2018.21253888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sl&#xfc;tter B., Pewe L.L., Kaech S.M., Harty J.T. Lung airway-surveilling CXCR3(hi) memory CD8(+) T&#xa0;cells are critical for protection against influenza A virus. Immunity. 2013;39:939&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3872058</ArticleId><ArticleId IdType="pubmed">24238342</ArticleId></ArticleIdList></Reference><Reference><Citation>Sl&#xfc;tter B., Van Braeckel-Budimir N., Abboud G., Varga S.M., Salek-Ardakani S., Harty J.T. Dynamics of influenza-induced lung-resident memory T&#xa0;cells underlie waning heterosubtypic immunity. Sci. Immunol. 2017;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5590757</ArticleId><ArticleId IdType="pubmed">28783666</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo P.A., Dogra P., Gray J.I., Wells S.B., Connors T.J., Weisberg S.P., Krupska I., Matsumoto R., Poon M.M.L., Idzikowski E., et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797&#x2013;814.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7951561</ArticleId><ArticleId IdType="pubmed">33765436</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo P.A., Miron M., Farber D.L. Location, location, location: tissue resident memory T&#xa0;cells in mice and humans. Sci. Immunol. 2019;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778482</ArticleId><ArticleId IdType="pubmed">30952804</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites R.S., Sanchez Sevilla Uruchurtu A., Siggins M.K., Liew F., Russell C.D., Moore S.C., Fairfield C., Carter E., Abrams S., Short C.E., et al. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci. Immunol. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128298</ArticleId><ArticleId IdType="pubmed">33692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B., Tonkin J., Devaraj A., Philip K.E.J., Orton C.M., Desai S.R., Shah P.L. CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology. 2021:211746. doi: 10.1148/radiol.2021211746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211746</ArticleId><ArticleId IdType="pmc">PMC8515207</ArticleId><ArticleId IdType="pubmed">34609195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Liu F., Zheng N.S., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Preprint at medRxiv. 2020 medRxiv:2020.2012.2010.20247205.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T., Hu Y., Lee Y.T., Bouchard K.R., Benechet A., Khanna K., Cauley L.S. Lung-resident memory CD8 T&#xa0;cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J.&#xa0;Leukoc. Biol. 2014;95:215&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896663</ArticleId><ArticleId IdType="pubmed">24006506</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita C.M., Dolgonos L., Zemans R.L., Young S.K., Robertson J., Briones N., Suzuki T., Campbell M.N., Gauldie J., Radisky D.C., et al. Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am. J. Pathol. 2011;179:1733&#x2013;1745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181358</ArticleId><ArticleId IdType="pubmed">21871427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005;4:17.</Citation><ArticleIdList><ArticleId IdType="pubmed">16646834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>